Skip to main content
Fig. 5  | Cardiovascular Diabetology

Fig. 5 

From: Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential

Fig. 5 

Relative expression (2−ΔCq, ΔCq = Cq has-miRNA—Cq U6) of miRNAs in MVs from the plasma of patients with dyslipidemia (n = 14), diabetes (n = 17), diabetes associated with dyslipidemia (n = 17) and of healthy subjects taken as control (n = 15): A miR-218-5p; B miR-212-5p; C miR-200b-3p; D miR-143-3p; E miR-132-3p; F miR-34a-5p. Data are expressed by means ± SD. &p < 0.05 (vs C), *p < 0.05 (vs DLP), #p < 0.05 (vs T2D), &&/**/##p < 0.01 (One-Way ANOVA with Bonferroni's Multiple Comparison Test)

Back to article page